The impact of frailty on the occurrence of immune-related adverse events in older patients with advanced melanoma.

Cheryl P. Bruijnen,Josephine J. Koldenhof,Erwin H.J. Tonk,Rik Jasper Verheijden,Frederiek van den Bos,Marielle H. Emmelot-Vonk,Petronella O. Witteveen,Karijn P.M. Suijkerbuijk

The impact of frailty on the occurrence of immune-related adverse events in older patients with advanced melanoma.

2020

Cheryl P. Bruijnen
Josephine J. Koldenhof
Erwin H.J. Tonk
Rik Jasper Verheijden
Frederiek van den Bos
Marielle H. Emmelot-Vonk
Petronella O. Witteveen
Karijn P.M. Suijkerbuijk

e24028Background: Immune checkpoint inhibitors (ICIs) have changed the melanoma treatment landscape by inducing durable responses and significantly improving survival. ICI can cause immune-related ...

Keywords:

Internal medicine
Immune system
older patients
Oncology
Physical therapy
Adverse effect
Medicine
advanced melanoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations